2010
DOI: 10.1089/ten.tec.2009.0228
|View full text |Cite
|
Sign up to set email alerts
|

Large-Scale Expansion of Pluripotent Human Embryonic Stem Cells in Stirred-Suspension Bioreactors

Abstract: Since the derivation of human embryonic stem (hES) cells, their translation to clinical therapies has been met with several challenges, including the need for large-scale expansion and controlled differentiation processes. Suspension bioreactors are an effective alternative to static culture flasks as they enable the generation of clinically relevant cell numbers with greater efficacy in a controlled culture system. We, along with other groups, have developed bioreactor protocols for the expansion of pluripote… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
83
0

Year Published

2011
2011
2016
2016

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 158 publications
(85 citation statements)
references
References 31 publications
(36 reference statements)
2
83
0
Order By: Relevance
“…Because massive numbers of hPSCs may be needed to address biomedical demands, namely, for cell therapy (e.g., 10 9 to 10 10 cells are required for heart or hepatic failure therapies) or drug-discovery pipelines (requiring ∼10 10 cells to screen a 1 million-compound library at once), the use of microcarrier-based bioreactors offers a more cost-effective system for high-production scales than planar technologies, as reported recently [9]. Our group and others have demonstrated successful expansion of hPSCs in stirred-tank bioreactors using different types of microcarriers [7,10,11]. Moreover, to meet regulatory safety concerns, Fan et al engineered xeno-free microcarriers for hPSC propagation in stirred suspension vessels, making the hPSCs more suitable for clinical applications [12].…”
Section: Introductionmentioning
confidence: 99%
“…Because massive numbers of hPSCs may be needed to address biomedical demands, namely, for cell therapy (e.g., 10 9 to 10 10 cells are required for heart or hepatic failure therapies) or drug-discovery pipelines (requiring ∼10 10 cells to screen a 1 million-compound library at once), the use of microcarrier-based bioreactors offers a more cost-effective system for high-production scales than planar technologies, as reported recently [9]. Our group and others have demonstrated successful expansion of hPSCs in stirred-tank bioreactors using different types of microcarriers [7,10,11]. Moreover, to meet regulatory safety concerns, Fan et al engineered xeno-free microcarriers for hPSC propagation in stirred suspension vessels, making the hPSCs more suitable for clinical applications [12].…”
Section: Introductionmentioning
confidence: 99%
“…Spinner flasks are one of the oldest and most widely used reactor systems and have been used extensively for the expansion of mouse as well as human ESC. Both mouse and human ESC have been expanded as aggregates in spinner flasks (Fok and Zandstra 2005;Cormier et al 2006;Abbasalizadeh et al 2012;Krawetz et al 2010;Steiner et al 2010). Extensive study in the field of large scale expansion of ES cells has given rise to novel and better systems for these cells but the field of dynamic culture of iPS cells has just started.…”
Section: Introductionmentioning
confidence: 99%
“…Stirred-suspension bioreactors (SSBs) [1][2][3] are an appealing culture modality for hPSC propagation and commitment given their scalability, robustly controlled operation, and widespread use in commercial production. hPSCs in these reactors can be grown as aggregates, 1,4 after encapsulation 5 or on microcarriers. 6,7 In particular, microcarrier systems afford high surface-to-volume ratio, homogenous environment, simple operation and continuous monitoring, and control of the culture environment.…”
mentioning
confidence: 99%